Jang Heub Kim

ORCID: 0000-0003-4202-1355
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Reproductive Biology and Fertility
  • Ovarian function and disorders
  • Gynecological conditions and treatments
  • Endometrial and Cervical Cancer Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Pelvic floor disorders treatments
  • Phytoestrogen effects and research
  • Reproductive System and Pregnancy
  • Minimally Invasive Surgical Techniques
  • Estrogen and related hormone effects
  • Ovarian cancer diagnosis and treatment
  • Pluripotent Stem Cells Research
  • Effects and risks of endocrine disrupting chemicals
  • Kruppel-like factors research
  • Health and Wellbeing Research
  • Sarcoma Diagnosis and Treatment
  • Menopause: Health Impacts and Treatments
  • TGF-β signaling in diseases
  • Biomedical Ethics and Regulation
  • Bone health and osteoporosis research
  • Healthcare and Venom Research
  • Birth, Development, and Health
  • Maternal and Perinatal Health Interventions

Seoul St. Mary's Hospital
2008-2018

Catholic University of Korea
1997-2018

Catholic University of America
2011

Osteocalcin, a marker of bone formation, is also known as regulator glucose and fat mass. The purpose this study was to determine the association between obesity, metabolic risks serum osteocalcin in postmenopausal women.We selected 214 women determined osteocalcin, fasting plasma (FPG), insulin, high-sensitivity C-reactive protein (hs-CRP), homeostasis model assessment insulin resistance (HOMA-IR), lipid profile, anthropometric values (body mass index [BMI], waist-to-hip ratio [WHR], body...

10.3109/09513590.2011.633660 article EN Gynecological Endocrinology 2011-11-24

Müllerian inhibiting substance (MIS) is produced in Sertoli cells of fetal testis and causes regression müllerian ducts male embryos. MIS also can induce the cell cycle arrest apoptosis duct-derived tumors vivo vitro.Our objective was to investigate expression type II receptor (MISR II) whether inhibit proliferation primary cultures endometrial stromal (ESC) endometriosis.In vitro experiments were performed university research laboratory.Tissue samples from 12 patients who had undergone...

10.1210/jc.2012-1538 article EN The Journal of Clinical Endocrinology & Metabolism 2012-07-04

Objectives:The aim of this study was to determine the relationship ovarian volume (OV) age, height, and weight in Korean young women with polycystic ovary syndrome (PCOS) undergoing ultrasonography (US) investigate between follicle count on US serum hormone levels including anti-Müllerian (AMH) gonadotropin.Methods: A total 272 nulliparous aged 15 39 years who were newly diagnosed PCOS at a university hospital included study.Evaluation ovaries measurement OVs all cases randomly performed by...

10.6118/jmm.2017.23.1.25 article EN cc-by-nc Journal of Menopausal Medicine 2017-01-01

<b><i>Background/Aims:</i></b> The purpose of this study was to identify predictive markers for tubo-ovarian abscess (TOA) through a comparison clinical and laboratory data in patients diagnosed with pelvic inflammatory disease (PID). <b><i>Methods:</i></b> We reviewed the medical charts 499 females who were admitted hospital clinical, surgical, imaging-based diagnoses PID between 2001 2011. divided into following two groups: (1) TOA (2)...

10.1159/000381772 article EN Gynecologic and Obstetric Investigation 2015-04-23

Background: Uterine artery embolization (UAE) is one of the minimally-invasive alternatives to hysterectomy for treatment uterine leiomyomas. There are various factors affecting outcomes UAE, but these have only been sporadically studied. Study Objective: To identify associated with efficacy UAE leiomyoma, and develop a model prediction response leiomyomas UAE. design: A retrospective cohort study (Canadian Task Force Classification II-2) Patients: One hundred ninety-eight patients...

10.7150/ijms.28687 article EN cc-by-nc International Journal of Medical Sciences 2018-01-01

Müllerian inhibiting substance (MIS), also known as anti-Müllerian hormone (AMH), is a member of the transforming growth factor-β (TGF-β) superfamily that plays an important role in mesenchymal-epithelial interaction, cell and proliferation, extracellular matrix production tissue remodeling. Previously, we demonstrated MIS suppressed ovarian cancer suggested large-scale genetic elements could be responsible for anti-neoplastic effects on cells. In this study, expression type II receptor...

10.3892/ijo.2011.1042 article EN International Journal of Oncology 2011-05-13

Müllerian inhibiting substance/anti-Müllerian hormone (MIS/AMH) has been suggested as a biotherapeutic agent in gynecological cancers that highly express the MIS/AMH type II receptors (MISRII/AMHRII) but anticancer mechanisms by which acts are not fully understood. Our experiments show inhibits ovarian cancer deregulating Wnt signal pathway via β-catenin interacting protein (ICAT). inhibition of ICAT small interfering RNAs (siRNA) decreased driven cell viability measured...

10.3892/ijo.2017.3874 article EN International Journal of Oncology 2017-02-13

10.1016/j.ejogrb.2017.05.018 article EN European Journal of Obstetrics & Gynecology and Reproductive Biology 2017-05-22

Müllerian-inhibiting substance/anti-Müllerian hormone (MIS/AMH) is produced in the ovarian granulosa cells, and it believed to inhibit folliculogenesis steroidogenesis women of reproductive age.To investigate expression MIS/AMH type II receptor (MISRII/AMHRII) that binds ovaries reproductive-age women; identify exact targets MIS/AMH.Laboratory study using human tissue.University hospital.Tissue samples from 25 patients who had undergone surgery.The segregation theca cells by laser...

10.1210/jc.2018-00549 article EN The Journal of Clinical Endocrinology & Metabolism 2018-06-26

Müllerian inhibiting substance (MIS) has been shown to inhibit growth of a number tumors in vitro and/or vivo, but the downstream pathways which it regulates are not fully understood. In present study we show that MIS type II receptor was highly expressed AN3CA cells, cell line derived from human endometrial cancer MIS-treatment caused reduction viability, and induced cellular apoptosis genes involved cycle arrest. To understand genome-wide effects on gene regulation, performed serial...

10.3892/ijo.2015.2920 article EN International Journal of Oncology 2015-03-06

Objectives: Metabolic syndrome components, insulin resistance and central obesity cause type 2 diabetes hypertension. This will increase the risk of cardiovascular disease. Women after menopause are at increased metabolic syndrome. Several researchers studied that in menopause, mortality. We impact on mortality postmenopausal women with Republic Korea. Methods: Twenty four thousand nine hundred forty aged 40 years or older were enrolled health promotion centers national university hospital...

10.6118/jksm.2012.18.1.6 article EN The Journal of Korean Society of Menopause 2012-01-01

The purpose of this study was to investigate the large-scale characteristic molecular signature Müllerian inhibiting substance (MIS) in human ovarian cancer cells through expression genomics. To understand comprehensive mechanisms by which MIS inhibits cell growth, we identified changes elicited line OVCAR-8, using DNA microarray analysis. Combined serial gene analysis from 0 96 h after treatment OVCAR-8 resulted 759 genes showed at least a 2-fold change overexpression or underexpression...

10.3892/ijmm_00000168 article EN International Journal of Molecular Medicine 2009-04-06

Abstract Although endometriosis is a common disease in women of reproductive age, rectal rare and lymph node involvement by considered uncommon. We report 37‐year‐old woman who had irregular lower abdominal pain changes bowel habits. She was operated on with suspected cancer, but the histological diagnosis involvement. In suffer from digestive complaints, should be differential diagnosis. Rectal has ability to invade adjacent tissue as true malignant tumors. Therefore, endometriosis.

10.1111/j.1447-0756.2010.01467.x article EN Journal of Obstetrics and Gynaecology Research 2011-04-04

We compared the expression levels of Müllerian inhibiting substance (MIS)/anti-Müllerian hormone type II receptor (AMHRII) in uterine myoma and adenomyosis to evaluate possibility using MIS/anti-Müllerian (AMH) as a biological regulator or therapeutic agent patients with leiomyoma adenomyosis.We studied normal myometrium, leiomyoma, endometrial tissue, from 57 who underwent hysterectomy for (22 cases) (28 myomectomy (7 cases). Immunohistochemical staining was used confirm MIS/AMHRII protein...

10.5468/ogs.2018.61.1.127 article EN cc-by-nc Obstetrics & Gynecology Science 2018-01-01

Objectives: Submucosal leiomyoma commonly causes abnormal uterine bleeding, menstrual abnormalities, and infertility, is usually treated by hysteroscopy. However, not all submucosal leiomyomas can be hysteroscopy; patients with high-scoring must undergo transabdominal myomectomy to preserve the uterus. This article reports experience a group of who underwent transvaginal radiofrequency (RF) thermal ablation grades, emphasis on safety efficacy this procedure. Study design: was prospective...

10.1089/gyn.2009.0101 article EN Journal of Gynecologic Surgery 2010-12-01

Research Question: To evaluate the effect of mistletoe on cell viability patients with endometriosis, expression levels vascular endothelial growth factor (VEGF) were measured, and change in level VEGF following treatment was recorded.Design: Forty reproductive-aged women endometriosis (stage I/II [group 1, n=20], stage III/IV 2, n=20]) prospectively enrolled.Twenty who underwent gynaecologic operations for benign conditions selected as control group.Both eutopic ectopic endometrial tissues...

10.7150/ijms.28470 article EN cc-by-nc International Journal of Medical Sciences 2018-01-01
Coming Soon ...